Preliminary Results of a Pilot Study Evaluating An Allogeneic GM-CSF Pancreatic Tumor Cell Vaccine (GVAX) and Cytoxan (Cy) With Stereotactic Body Radiation Therapy (SBRT) and Folfirinox (FFX) in Patients With Resected Pancreatic Adenocarcinoma

Favorable Perioperative and Survival Outcomes After Resection of Borderline Resectable Pancreatic Cancer Treated With Neoadjuvant Stereotactic Radiation and Chemotherapy Compared With Upfront Pancreatectomy for Resectable Cancer E.A. Mellon, T. Strom, S.E. Hoffe, J.M. Frakes, G.M. Springett, P.J. Hodul, M.P. Malafa, M.D. Chuong, and R. Shridhar; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, University of Maryland School of Medicine, Baltimore, MD